MYND Life Sciences Company Description

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.

MYND Life Sciences Inc.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	John Campbell

Contact Details

Address: Unit 150 Port Coquitlam, British Columbia V3C 2B2 Canada
Website	myndsciences.com

Stock Details

Ticker Symbol	MYND
Exchange	Canadian Securities Exchange
Fiscal Year	November - October
Reporting Currency	CAD
ISIN Number	CA62857B1094
SIC Code	2834

Key Executives

Name	Position
John Campbell	President,Chief Executive Officer and Director
Dr. Wilfred A. Jefferies	Co-Founder and Chief Science Officer
Lih-Ming Tam	Chief Financial Officer and Senior Controller
Dr. Lyle Oberg M.D.	Co-Founder and Executive Chairman of the Board
Dr. Chaahat S.B Singh	Senior Operations and Research Manager
Luke Warkentin	Vice President of Corporate Development
Dr. Iryna Saranchova M.D., Ph.D.	Chief Clinical Officer